This inventor holds 1 USPTO granted patent. Top assignee: Eisai Company, Limited. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: **Kiyomi Kikuchi: Innovating Lipid A Analog Evaluations**
Introduction
Kiyomi Kikuchi is an esteemed inventor based in Ibaraki, Japan, recognized for her contributions to the field of pharmaceuticals. With a pioneering spirit, she has developed innovative processes that enhance the evaluation of lipid A analog-containing injections.
Latest Patents
Kikuchi holds a patent entitled "Method for Evaluating Lipid A Analog-Containing Injections." This significant invention presents a comprehensive evaluation method and preparation process for injections that include a lipid A analog or its pharmacologically acceptable salts. Her invention provides forecasting and evaluating methods of the pharmacokinetics of lipid A analog, complemented by quality evaluation methods and preparation processes. These methods involve measuring membrane fluidity and/or circular dichroism, ensuring the efficacy and safety of the injections.
Career Highlights
Kiyomi Kikuchi is currently affiliated with Eisai Company, Limited, a well-respected entity in the pharmaceutical industry. Her work at Eisai emphasizes her commitment to advancing drug formulation and evaluation methodologies that directly impact therapeutic practices and patient care.
Collaborations
Throughout her career, Kikuchi has collaborated with notable colleagues such as Kazuhiro Kaneko and Tomohiro Watanabe. These partnerships have fostered a dynamic environment for innovation and excellence in their shared pursuits within the pharmaceutical domain.
Conclusion
Kiyomi Kikuchi exemplifies the spirit of innovation in the field of pharmaceuticals. Her groundbreaking patent for evaluating lipid A analog-containing injections not only advances scientific understanding but also enhances practical applications in medicine. Through her work and collaborations, she continues to contribute significantly to the healthcare sector, paving the way for more effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
